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tic undifferentiated carcinoma. She underwent left lateral hepatectomy 
in January 2006. Histopathology conﬁrmed metastatic rhabdoid tumor 
with negative margins of resection. She received further chemotherapy 
with six cycles of injection Docetaxel (75mg/m2) i.v. D1 3 weekly from 
February 2006 to June 2006. 
Result: Follow up PET scan in July 2006 showed no evidence of 
disease. A repeat PET scan in February 2007 showed a sustained remis-
sion. 
Conclusion: The present case shows that with aggressive management, 
long term remission can be achieved in rhabdoid tumor of lung. 
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percent-
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Cytokeratin 3/6 9/11 12/14 3/3 27/34 79.4
Epithelial membrane 
antigen 5/6 X 6/14 3/3 14/23 60.8
Vimentin 6/6 11/11 14/14 3/3 34/34 100
S-100 0/6 X X 0/3 0/9  
HMB-45 0/6 X 0/14 X 0/20  
CAM 5.2 2/6 X X X 2/6 33.3
Glial Fibrillary acidic 
Protein 1/6 X 0/14 X 1/20 5
Chromogranin 2/6 X 2/14 3/3 7/23 30.4
Neuroﬁlaments 2/6 X 1/14 X 3/20 15
Neuron Speciﬁc 
Enolase 5/6 X 5/14 2/3 12/23 52
Factor VIII 0/6 X X X 0/6  
CD 34 1/6 X 1/14 X 2/20 10
Muscle Speciﬁc Actin 0/6 X X X 0/6  
Desmin 0/6 X 0/14 0/3 0/20  
Myoglobin 1/6 X 0/14 0/3 1/20 5
Cytokeratin 7 X 4/11 X X 4/11 36.3
Cytokeratin 20 X 0/11 X X 0/11  
Thyroid Transcription 
Factor-1 X 0/11 X X 0/11  
Synaptophysin X X 1/14 2/3 3/17 17
CD 57 X X 0/14 X 0/14  
c-kit X X 0/14 X 0/14  
HHF-35 X X 0/14 0/3 0/17  
Surfactant  
Apoprotein A X X X 1/3 1/3 33.3
CD56 X X X 1/3 1/3 33.3
GM-CSF X X X 1/3 1/3 33.3
G-CSF X X X 1/3 1/3 33.3
p53 X X X 0/3 0/3  
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Introduction: Bronchioloalveolar Lung Carcinoma (BALC) has long 
been an entity with particular characteristics, discussed over several 
decades. Its diagnosis, treatment and prognosis differ somewhat from 
other histological types of lung carcinoma. In 2003, the World Health 
Organization redeﬁned the pathologic characteristics of the BALC. Ac-
cording to these, only histological data allow its diagnosis.
Objectives: The authors aim to observe and discuss the repercussions 
of the new classiﬁcation criteria for BALC on its prognosis and associ-
ated survival, in patients submitted to lung surgery.
Material and Methods: Retrospective analysis of 18 patients submit-
ted to either diagnostic or curative surgery for lung carcinoma between 
years 2001 and 2005, diagnosed with BALC. Initial histological 
diagnoses were revised according to the recently adopted criteria for 
BALC, leading to the distinction of two separate groups: “pure” BALC 
and Mixed adenocarcinoma. Analysis of lesion size, TNM staging, 
need for chemo- (QT) or radio- (RT) adjuvant therapy as well as mean 
survival were compared among these 2 groups.
Results: 
Histological Type BALC Mixed Total
Total number of patients 7 11 18
Number of male patients 2 7 9
Mean age (years) 60.1 58.5 59.1
Mean Mass diameter (cm) 3.04 4.47 3.84
Mean survival (months) 38.1 28.6 32.3
1-year survival rate (%) 100 63.6 77.8
Fatalities 3 (42.9%) 6 (54.5%) 9 (50%)
Ia 4 2 6
Ib 3 3 6
IIb - 3 3
IIIb - 3 3
QT 1 7 8
RT - 5 5
Discussion: Despite the small sample size, some simple facts stand out: 
• Patient age was slightly lower and mass diameter larger in the mixed 
group;
• There was a greater predominance of advanced TNM stages in the 
“mixed” group, an expected fact taking the deﬁnition of BALC in 
itself into account;
• But one patient in the BALC group was submitted to chemotherapy 
and none to radiotherapy; on the other hand, a great proportion of 
patients in the “mixed” group was submitted to these treatments; 
• The relative number of deaths was slightly larger in the “Mixed” 
group;
• 1-year survival rate was of 100% in the BALC group unlike the 
Mixed group where it was of 63.6%;
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• BALC patient post-surgical survival period was greater than the 
“Mixed” group one.
Discussion: The characterization of the BALC as a separate entity with 
particular characteristics appears to have practical and objective effects 
in the determination of this disease’s prognosis. This population sample 
analysis seems to verify the importance of this new classiﬁcation. Fu-
ture analysis with larger samples and for longer follow-up periods may 
further support these data.
P1-176 Pathology Posters, Mon, Sept 3 
Effects of vascular endothelial growth factors (VEGFs) on 
biological behavior of intrathoracic lung cancer cells
Shimoyamada, Hiroaki1 Yazawa, Takuya1 Sato, Hanako2 Okudela, Koji1 
Kitamura, Hitoshi1 
1 Dept. of Pathobiology, Yokohama City University Graduate School of 
Medicine, Yokohama, Japan 2 Dept. of Anatomy, St. Marianna Univer-
sity, Kawasaki, Japan 
Background: The expression of vascular endothelial growth factors 
(VEGFs) in tumors including lung cancer is considered to be associ-
ated with tumor development via angiogenesis and lymphangiogenesis. 
Pleural dissemination and lymph node metastasis of lung cancer are 
major poor prognostic factors. We investigate how VEGF-A, VEGF-C, 
and VEGF-D expressed in the intrathoracic inﬁltrating lung cancer cells 
are involved in dissemination and metastasis. 
Methods: We established large cell lung cancer cell lines in which 
stably VEGF-A-, VEGF-C-, VEGF-D-, or VEGF-C and VEGF-D were 
stably expressed (TKB5/VEGF-A, TKB5/VEGF-C, TKB5/VEGF-D, 
TKB5/VEGF-C/D, respectively). These transfectants were orthotopi-
cally inoculated into the right thoracic cavity (i.t.) of nude mice, and 
then we evaluated subsequent development of pleural effusion, pleural 
dissemination, and lymph node metastasis. 
Results: There were no signiﬁcant differences in cell growth rate 
among the control lines (empty vector-transfected TKB5) and VEGF-
transfectants in vitro. However, each i.t. model demonstrated signiﬁ-
cantly different biological properties. TKB5/empty showed no apparent 
pleural effusion, dissemination, or lymph node metastasis. In contrast, 
TKB5/VEGF-A, TKB5/VEGF-C, TKB5/VEGF-D, and TKB5/VEGF-
C/D promoted bloody pleural effusion and dissemination (4/4, 4/7, 4/4, 
and 5/10, respectively). TKB5/VEGF-D and TKB5/VEGF-C/D showed 
aggressive mediastinal invasion around the thoracic aorta and thoracic 
duct. Furthermore, TKB5/VEGF-C/D generated mediastinal lymph 
node metastasis (2/10). These ﬁndings suggested that VEGF-D could 
facilitate mediastinal spread of lung cancer cells. Immunohistochemi-
cal study revealed that the expression of both VEGF-A and VEGF-D in 
the disseminated tumor promoted intense blood vessel formation rather 
than lymph vessel formation. In contrast, TKB5/VEGF-C showed mild 
increase of lymph vessel density and signiﬁcantly low blood vessel 
density in the disseminated tumor. 
Conclusions: The biological behavior of lung cancer cells within 
the thoracic cavity appears to be regulated by expression patterns of 
VEGFs. The regulation of the expression of VEGFs in intrathoracic 
lung cancer cells might be a useful therapeutic approach to inhibit 
tumor development and improve patient prognosis. 
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Background: Endoscopic ultrasound guided ﬁne needle aspiration 
biopsy through the oesophagus (EUS-FNA) or the bronchial tree 
(Endobronchial ultrasound guided transbronchial needle aspiration 
(EBUS-TBNA)) may be used to obtain specimens from mediastinal 
structures. However, no studies have studied the reproducibility of the 
pathological assessment of the aspirated material. 
Methods: 102 slides from EUS-FNA or EBUS-TBNA were assessed 
two times by four pathologists who classiﬁed each slide to one of ﬁve 
diagnostic categories, and judged if the aspirate came from a lymph 
node. Between the two rounds, the criteria to be used in the assessment 
of the slides were reviewed in a limited education session.
The four observers had at least 15 years of pathology experience, but 
their experience in EUS-FNA and/or EBUS TBNA varied from almost 
none to more than 20 years. The Kappa statistic was applied for the 
analysis of reproducibility.
Results: The reproducibility of the diagnoses in the ﬁrst round was 
good to excellent (Kappa 0.52-0.89). The teaching session led to a 
signiﬁcant improvement of the reproducibility between the least and 
the most experienced observers (Kappa ranges of 0.52-0.55 in the ﬁrst 
round improved to 0.65-0.71 in the second round). 
Conclusion: The reproducibility of the diagnosis on EBUS-TBNA and 
EUS-FNA is excellent among pathologists experienced with this type of 
samples. Pathologists who are generally experienced but have little ex-
perience with EBUS-TBNA and EUS-FNA show a steep learning curve. 
From a pathologic point of view, EBUS-TBNA and EUS-FNA are 
feasible, but only experienced pathologists should do the assessments. 
P1-178 Pathology Posters, Mon, Sept 3 
Synchronous multisystemic(pulmonary and gastrointestinal) 
extranodal marginal zone lymphoma of malt type and two lung 
carcinomas with different histologic and immunophenotypic 
features
Gürel, Duygu1 Tayfur, Devrim1 Sanli, Aydin2 Turan, Onur3 Karacam, 
Volkan2 Akkoclu, Atila3 Kargi, Aydanur1 
1 Dokuz Eylul University the Faculty of Medicine Pathology Depart-
ment, Izmir, Turkey 2 Dokuz Eylul University the Faculty of Medicine 
Chest Surgery Department, Izmir, Turkey 3 Dokuz Eylul University the 
Faculty of Medicine Chest Diseases Department, Izmir, Turkey 
A case with two different primary lung tumor which had different mor-
phologic and immunophenotypic features and associated multisystemic 
MALT type extranodal (lung, stomach, duodenum) marginal zone 
lymphoma is reported.
